In vitro gallbladder motility in patients with radiolucent and radiopaque stones

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Twenty-five gallbladders were studied in vitro. Sixteen had radiolucent gallstones and 9 had radiopaque gallstones. The radiolucent gallstones had a cholesterol content of 94.17 ± 3.76% and the radiopaque gallstones had a cholesterol content of 56.6 ± 4.46%. Half the maximal response (ED50) to cholecystokinin octapeptide (CCK-OP) and to carbachol in strips from patients with radiolucent gallstones was 0.8 ±0.15 and 27.01 ± 3.74 × 10-7 M. respectively. In strips from patients with radiopaque gallstones, the ED50 was 0.4 ± 0.08 and 14.92 ± 3.07 × 10-7 M, respectively. The ED50 values to CCK-OP and carbachol were greater in strips from specimens with radiolucent gallstones than in strips from specimens with radiopaque gallstones (p <0.05). There was no significant difference in the maximal contractile response of the two groups. It can be concluded that gallbladder sensitivity to CCK-OP and carbachol can be modified in relation to differences in the cholesterol and calcium content of the stones.

Original languageEnglish
Pages (from-to)22-27
Number of pages6
JournalDigestion
Volume50
Issue number1
DOIs
Publication statusPublished - 1991

Fingerprint

Gallstones
Gallbladder
Sincalide
Carbachol
Cholesterol
In Vitro Techniques
Calcium

Keywords

  • Carbachol
  • Cholecystokinin octapeptide
  • Gallbladder motility
  • Radiolucent gallstones
  • Radiopaque gallstones

ASJC Scopus subject areas

  • Gastroenterology

Cite this

In vitro gallbladder motility in patients with radiolucent and radiopaque stones. / Maselli, M. A.; Messa, C.; Pezzolla, F.; Riezzo, G.; Caruso, M. L.; Di Leo, A.

In: Digestion, Vol. 50, No. 1, 1991, p. 22-27.

Research output: Contribution to journalArticle

@article{2883b7d6449349948741ca4aac1df473,
title = "In vitro gallbladder motility in patients with radiolucent and radiopaque stones",
abstract = "Twenty-five gallbladders were studied in vitro. Sixteen had radiolucent gallstones and 9 had radiopaque gallstones. The radiolucent gallstones had a cholesterol content of 94.17 ± 3.76{\%} and the radiopaque gallstones had a cholesterol content of 56.6 ± 4.46{\%}. Half the maximal response (ED50) to cholecystokinin octapeptide (CCK-OP) and to carbachol in strips from patients with radiolucent gallstones was 0.8 ±0.15 and 27.01 ± 3.74 × 10-7 M. respectively. In strips from patients with radiopaque gallstones, the ED50 was 0.4 ± 0.08 and 14.92 ± 3.07 × 10-7 M, respectively. The ED50 values to CCK-OP and carbachol were greater in strips from specimens with radiolucent gallstones than in strips from specimens with radiopaque gallstones (p <0.05). There was no significant difference in the maximal contractile response of the two groups. It can be concluded that gallbladder sensitivity to CCK-OP and carbachol can be modified in relation to differences in the cholesterol and calcium content of the stones.",
keywords = "Carbachol, Cholecystokinin octapeptide, Gallbladder motility, Radiolucent gallstones, Radiopaque gallstones",
author = "Maselli, {M. A.} and C. Messa and F. Pezzolla and G. Riezzo and Caruso, {M. L.} and {Di Leo}, A.",
year = "1991",
doi = "10.1159/000200736",
language = "English",
volume = "50",
pages = "22--27",
journal = "Digestion",
issn = "0012-2823",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - In vitro gallbladder motility in patients with radiolucent and radiopaque stones

AU - Maselli, M. A.

AU - Messa, C.

AU - Pezzolla, F.

AU - Riezzo, G.

AU - Caruso, M. L.

AU - Di Leo, A.

PY - 1991

Y1 - 1991

N2 - Twenty-five gallbladders were studied in vitro. Sixteen had radiolucent gallstones and 9 had radiopaque gallstones. The radiolucent gallstones had a cholesterol content of 94.17 ± 3.76% and the radiopaque gallstones had a cholesterol content of 56.6 ± 4.46%. Half the maximal response (ED50) to cholecystokinin octapeptide (CCK-OP) and to carbachol in strips from patients with radiolucent gallstones was 0.8 ±0.15 and 27.01 ± 3.74 × 10-7 M. respectively. In strips from patients with radiopaque gallstones, the ED50 was 0.4 ± 0.08 and 14.92 ± 3.07 × 10-7 M, respectively. The ED50 values to CCK-OP and carbachol were greater in strips from specimens with radiolucent gallstones than in strips from specimens with radiopaque gallstones (p <0.05). There was no significant difference in the maximal contractile response of the two groups. It can be concluded that gallbladder sensitivity to CCK-OP and carbachol can be modified in relation to differences in the cholesterol and calcium content of the stones.

AB - Twenty-five gallbladders were studied in vitro. Sixteen had radiolucent gallstones and 9 had radiopaque gallstones. The radiolucent gallstones had a cholesterol content of 94.17 ± 3.76% and the radiopaque gallstones had a cholesterol content of 56.6 ± 4.46%. Half the maximal response (ED50) to cholecystokinin octapeptide (CCK-OP) and to carbachol in strips from patients with radiolucent gallstones was 0.8 ±0.15 and 27.01 ± 3.74 × 10-7 M. respectively. In strips from patients with radiopaque gallstones, the ED50 was 0.4 ± 0.08 and 14.92 ± 3.07 × 10-7 M, respectively. The ED50 values to CCK-OP and carbachol were greater in strips from specimens with radiolucent gallstones than in strips from specimens with radiopaque gallstones (p <0.05). There was no significant difference in the maximal contractile response of the two groups. It can be concluded that gallbladder sensitivity to CCK-OP and carbachol can be modified in relation to differences in the cholesterol and calcium content of the stones.

KW - Carbachol

KW - Cholecystokinin octapeptide

KW - Gallbladder motility

KW - Radiolucent gallstones

KW - Radiopaque gallstones

UR - http://www.scopus.com/inward/record.url?scp=0026342572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026342572&partnerID=8YFLogxK

U2 - 10.1159/000200736

DO - 10.1159/000200736

M3 - Article

C2 - 1804729

AN - SCOPUS:0026342572

VL - 50

SP - 22

EP - 27

JO - Digestion

JF - Digestion

SN - 0012-2823

IS - 1

ER -